Скачайте изображение (превью) выбрав качество

320x180 480x360 640x480 1280x720

Dr Erin D Michos, preventive cardiologist, (Johns Hopkins University School of Medicine, US) joined us in New Orleans to comment on the new data from the CLEAR-Outcomes trial, that looked at the impact of bempedoic acid (ETC-1002) on the occurrence of major cardiovascular events in patients with cardiovascular disease or those at high risk of developing it who are statin intolerant. Dr Michos also highlights the gaps in primary prevention in current clinical practice.

For more content from ACC.23/WCC and the Late-breaker Discussion series head to Late-Breaking Science Video Collection.

Recorded on-site at ACC.23/WCC, New Orleans.

Visit Radcliffe Cardiology:

This content is intended for healthcare professionals only.

Radcliffe brings medical knowledge, insight and innovation to life for CV clinicians around the world, using our communications & creative expertise, our platforms and connections across the community to help transform theory into practice faster.

Like us on Facebook:
Follow us on Twitter:

Чтобы скачать видео "ACC 23: Lipid Management & the CLEAR Trial with Dr Michos" передвинте ползунок вправо